Klaus GraumannCEO and Co-Founder at PhoenestraSpeaker
Profile
20 years of biopharma industry experience and operational with Phoenestra since 2021 in establishing technology platforms which enable cell-derived therapeutics for unmet medical needs
Agenda Sessions
Targeting Significant Unmet Medical Need with Extracellular Vesicles from MSC
, 09:10View Session